4.7 Article

Proteomic analysis of succinate dehydrogenase and ubiquinol-cytochrome c reductase (Complex II and III) isolated by immunoprecipitation from bovine and mouse heart mitochondria

Journal

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbadis.2005.07.003

Keywords

mitochondria; succinate dehydrogenase; ubiquinol-cytochrome c reductase; posttranslational modification; neurodegenerative disease

Funding

  1. NINDS NIH HHS [R21 NS 043620-01] Funding Source: Medline

Ask authors/readers for more resources

The oxidative phosphorylation system (OXPHOS) consists of five multi-enzyme complexes, Complexes I-V and is a key component of mitochondrial function relating to energy production, oxidative stress, cell signaling and apoptosis. Defects or a reduction in activity in various components that make up the OXPHOS enzymes can cause serious diseases, including neurodegenerative disease and various metabolic disorders. Our goal is to develop techniques that are capable of rapid and in-depth analysis of all five OXPHOS complexes. Here, we describe a mild, micro-scale immunoisolation and mass spectrometric/proteomic method for the characterization of Complex II (succinate dehydrogenase) and Complex III (ubiquinol-cytochrome c reductase) from bovine and rodent heart mitochondria. Extensive protein sequence coverage was obtained after immunocapture, 1D SDS PAGE separation and mass spectrometric analysis for a majority of the 4 and II subunits, respectively, that make up Complexes II and III. The identification of several posttranslational modifications,, including the covalent FAD modification of flavoprotein subunit I from Complex II, was possible due to high mass spectrometric sequence coverage. (C) 2005 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available